Press Releases

Unedited news and product information from vendors.

Frost & Sullivan Acknowledges Accelrys for Scientific Informatics Solution
Sep 16, 2010 (04:09 PM EDT)


Accelerating the Scientific Process Underlying Drug Discovery

MOUNTAIN VIEW, Calif., Sept. 16 /PRNewswire/ -- Based on its recent analysis of the integrated in silico drug discovery solutions market, Frost & Sullivan recognizes Accelrys, Inc., with the 2010 North America Frost & Sullivan Award for New Product Innovation of the Year. The company has merited this award for its Pipeline Pilot™ scientific informatics platform, a solution that provides, for the first time, a suitable automated workflow system that can be integrated into the information systems used by scientists in the pharmaceuticals, life sciences and materials industries.

(Logo:  http://photos.prnewswire.com/prnh/20081117/FSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

While Accelrys' competitors have focused on developing technologies across specialized areas of the workflow, Accelrys developed a product that can manage and synthesize information, and most importantly, create scope for incremental innovation by the customer. This could potentially be built into the product through the course of its usage, thus bringing about high-end customization of the offering.

A fundamental challenge in the drug discovery space has been the need to accelerate the new drug discovery process This core requirement has been largely neglected and underdeveloped due to the uneven dispersal of clinical data and the lack of a streamlined process optimization solution. The industry needed a solution that could integrate workflows and enable analyses of systems for developing a core organizational structure for the life sciences and pharmaceutical network.

"Accelrys' Pipeline Pilot™ exemplifies an effective solution to provide a scientifically viable biomedical informatics solution that potentially accelerates the scientific process underlying drug discovery. This process streamlines workflow and offers a common platform for integrated data management and distribution," says Frost & Sullivan Research Analyst Bhuvaneashwar Subramanian.

Fundamentally, the Pipeline Pilot™ scientific informatics platform is a workflow process automation solution that aggregates data from disparate sources and reduces silos through the extraction of scientific data. This automates the process of data management and enables predictive analytics, thereby enhancing the scope for scientific collaboration and hastening processes in the clinical sciences.

"The Pipeline Pilot™ scientific informatics platform offers a host of benefits including superior predictive modeling systems and the possibility of reducing the completion times of R&D products by at least 10 times by lowering investment in direct bench-top research," notes Subramanian. "Furthermore, by using integrated dashboard systems, it becomes possible to make instant decisions and reduce R&D costs through focused in silico database utilization and integration."

Each year, Frost & Sullivan presents this award to the company that has demonstrated innovation in developing a product. The recipient has leveraged leading-edge technologies to offer value-added features while increasing the ROI for customers. In turn, the innovation has enabled the company to acquire new customers and increase their market penetration.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific informatics software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific informatics platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. In July 2010, Accelrys and Symyx Technologies, Inc. merged, combining the market-leading Symyx electronic laboratory notebook, decision support software, and chemical informatics and sourcing databases with the Accelrys portfolio of scientific informatics solutions. For more information about Accelrys and Symyx solutions, visit www.accelrys.com  and www.symyx.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.

Contact:

Jake Wengroff

210.247.3806

jake.wengroff@frost.com



SOURCE Frost & Sullivan